TTTakafumi Tsukui

Takafumi Tsukui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takafumi Tsukui has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Atsuyuki Yamataka

    Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan

    1 shared publication
  • Geoffrey Lane

    Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan

    1 shared publication
  • Go Miyano

    Department of Pediatric General and Urogenital Surgery Juntendo University School of Medicine Tokyo Japan

    1 shared publication
  • Hiroki Nakamura

    Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan

    1 shared publication
  • Hiroshi Murakami

    Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan

    1 shared publication
  • Hiroyuki Koga

    Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan

    1 shared publication

Latest Publications

  • Biochemical Evaluation of Laparoscopic Portoenterostomy for Treating Biliary Atresia and Redo for Failed Portoenterostomy

    by Takafumi Tsukui, Hiroyuki Koga, Joel Cazares, Shunsuke Yamada, Hiroshi Murakami, Soichi Shibuya, Hiroki Nakamura, Takanori Ochi, Koichi Tsuboi, Geoffrey Lane, et al.

    Background: Postoperative outcomes of portoenterostomy (PE) and redo-PE were evaluated using selected biochemical markers (SBM) and biochemical status categories (BSC). Methods: Subjects were 70 consecutive PE performed for biliary atresia. SBM were aspartate aminotransferase (AST)/alanine aminotransferase (ALT), cholinesterase (ChE), and platelet count (PLT) assessed at 1, 2, 3, 6, and 12 months, and thence, annually for a maximum of 10 years. BSC were as follows: all SBM normal (N-SBM), normal AST/ALT (N-SLT), normal ChE (N-ChE), normal PC (N-PLT), all abnormal (A-SBM), abnormal AST/ALT (A-SLT), abnormal ChE (A-ChE), and abnormal PC (A-PLT). Subjects achieving jaundice clearance (JC) and surviving with native livers (SNL) also had gamma glutamyl transpeptidase assessed. Redo-PE indicated for failed PE was assessed postoperatively using the same SBM/BSC protocol. Results: PE were laparoscopic (LPE; n = 40) or open (OPE; n = 30). Mean age/weight at PE and duration of follow-up were similar. For JC, LPE = 34/40 (85.0%) and OPE = 22/30 (73.3%); P = .23. For SNL, LPE = 29/40 (72.5%) and OPE = 16/30 (53.3%); P = .10. LPE and OPE were similar for SBM/BSC, except for a single significant increase in ALT in OPE at 6 months. Redo-PE was performed 17–180 days (mean 67.1 days) after primary PE. AST was significantly increased at the last preredo assessment 3 months after primary PE; P < .05. After redo, AST decreased and SBM/BSC results were equivalent to nonredo subjects. Conclusion: Postoperative biochemical data for all PE cases were comparable; redo-PE would appear to be viable for restoring SBM, and AST could be valuable as a single marker of deterioration in redo cases.